1. Home
  2. INTT vs QNCX Comparison

INTT vs QNCX Comparison

Compare INTT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • QNCX
  • Stock Information
  • Founded
  • INTT 1981
  • QNCX 2012
  • Country
  • INTT United States
  • QNCX United States
  • Employees
  • INTT N/A
  • QNCX N/A
  • Industry
  • INTT Semiconductors
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INTT Technology
  • QNCX Health Care
  • Exchange
  • INTT Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • INTT 77.3M
  • QNCX 47.7M
  • IPO Year
  • INTT 1997
  • QNCX 2019
  • Fundamental
  • Price
  • INTT $7.14
  • QNCX $1.73
  • Analyst Decision
  • INTT Strong Buy
  • QNCX Strong Buy
  • Analyst Count
  • INTT 2
  • QNCX 5
  • Target Price
  • INTT $12.00
  • QNCX $8.00
  • AVG Volume (30 Days)
  • INTT 27.8K
  • QNCX 294.4K
  • Earning Date
  • INTT 08-01-2025
  • QNCX 08-12-2025
  • Dividend Yield
  • INTT N/A
  • QNCX N/A
  • EPS Growth
  • INTT N/A
  • QNCX N/A
  • EPS
  • INTT N/A
  • QNCX N/A
  • Revenue
  • INTT $127,503,000.00
  • QNCX N/A
  • Revenue This Year
  • INTT N/A
  • QNCX N/A
  • Revenue Next Year
  • INTT $10.07
  • QNCX N/A
  • P/E Ratio
  • INTT N/A
  • QNCX N/A
  • Revenue Growth
  • INTT 5.19
  • QNCX N/A
  • 52 Week Low
  • INTT $5.24
  • QNCX $0.51
  • 52 Week High
  • INTT $11.87
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • INTT 49.67
  • QNCX 64.55
  • Support Level
  • INTT $7.12
  • QNCX $1.55
  • Resistance Level
  • INTT $8.14
  • QNCX $2.05
  • Average True Range (ATR)
  • INTT 0.45
  • QNCX 0.16
  • MACD
  • INTT -0.05
  • QNCX 0.01
  • Stochastic Oscillator
  • INTT 14.29
  • QNCX 49.21

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: